How Esketamine Eliminated in 75% of Postpartum Depression
The study explored the effect of a single low dose of esketamine administered post-childbirth in mothers with prenatal depression. The trial found that the intervention significantly reduced the incidence of postpartum major depressive episodes by about three-quarters compared to a placebo.